24-Month results of the BRAVO study: A prospective, multi-center study evaluating the clinical outcomes of a ventral hernia cohort treated with OviTex® 1S permanent reinforced tissue matrix

BACKGROUND: This study evaluated the performance of OviTex® 1S (TELA Bio Inc., Malvern, PA, USA) over 24 months when used for ventral hernia repair. METHODS: This was a prospective, single-arm, multi-center clinical trial (ClinicalTrials.gov/NCT03074474). A ninety-two patient cohort with ventral her...

Descripción completa

Detalles Bibliográficos
Autores principales: DeNoto, George, Ceppa, Eugene P., Pacella, Salvatore J., Sawyer, Michael, Slayden, Geoffrey, Takata, Mark, Tuma, Gary, Yunis, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661641/
https://www.ncbi.nlm.nih.gov/pubmed/36389188
http://dx.doi.org/10.1016/j.amsu.2022.104745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661641/
https://www.ncbi.nlm.nih.gov/pubmed/36389188
http://dx.doi.org/10.1016/j.amsu.2022.104745

Ejemplares similares